Etanercept Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Benepali, Enbrel, Others); Application (Arthritis, Psoriasis, Spondylitis) and Geography

Report Code: TIPRE00018520 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Etanercept is a biopharmaceutical anti-Tumor Necrosis Factor (TNF) that used in a treatment of autoimmune diseases such as spondylitis and arthritis. Excessive production of TNF in the body causes pain, Inflammation, and damage to the bones and joints. Etanercept blocks the action of TNF and decreases the inflammation. Etanercept is prescribed to treat rheumatoid arthritis, Juvenile rheumatoid arthritis, plaque psoriasis, Psoriatic arthritis and ankylosing spondylitis.

MARKET DYNAMICS

The key market drivers for Etanercept Market Includes, rising prevalence of spondylitis and arthritis along with rising incidences of accidents and obesity. Additionally, government initiatives for creating awareness about arthritis along with increasing healthcare expenditure is expected to boost market growth during forecast period. Whereas, stringent regulatory approvals for safety and efficacy and etanercept and several side effects from etanercept are expected to have negative impact on market growth.

MARKET SCOPE

The "Etanercept Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Etanercept market with detailed market segmentation by Product, application. The Etanercept Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Etanercept Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Etanercept Market is segmented on the basis of Product and application. On the basis of product the market is segmented as, benepali, Enbrel, others. And on the basis of application the market is segmented as, arthritis, psoriasis and spondylitis.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Etanercept Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Etanercept Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Etanercept Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Etanercept Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Etanercept Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Etanercept Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Etanercept market in the global market. Below mentioned is the list of few companies engaged in the Etanercept Market.

The report also includes the profiles of key players in Etanercept Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Pfizer, Inc.
  •   Takeda Pharmaceutical Company Ltd.
  •   Johnson and Johnson
  •   GlaxoSmithKline Pharmaceuticals, Ltd
  •   Samsung Bioepis Co., Ltd.
  •   F. Hoffmann-La Roche Ltd.
  •   Cipla Limited
  •   Novartis International AG
  •   Celltrion Inc.
  •   Immunex Corporation

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Etanercept Market - By Product
1.3.2 Etanercept Market - By Application
1.3.3 Etanercept Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. ETANERCEPT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. ETANERCEPT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. ETANERCEPT MARKET - GLOBAL MARKET ANALYSIS
6.1. ETANERCEPT - GLOBAL MARKET OVERVIEW
6.2. ETANERCEPT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. ETANERCEPT MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. BENEPALI
7.3.1. Overview
7.3.2. Benepali Market Forecast and Analysis
7.4. ENBREL
7.4.1. Overview
7.4.2. Enbrel Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. ETANERCEPT MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ARTHRITIS
8.3.1. Overview
8.3.2. Arthritis Market Forecast and Analysis
8.4. PSORIASIS
8.4.1. Overview
8.4.2. Psoriasis Market Forecast and Analysis
8.5. SPONDYLITIS
8.5.1. Overview
8.5.2. Spondylitis Market Forecast and Analysis

9. ETANERCEPT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Etanercept Market Overview
9.1.2 North America Etanercept Market Forecasts and Analysis
9.1.3 North America Etanercept Market Forecasts and Analysis - By Product
9.1.4 North America Etanercept Market Forecasts and Analysis - By Application
9.1.5 North America Etanercept Market Forecasts and Analysis - By Countries
9.1.5.1 United States Etanercept Market
9.1.5.1.1 United States Etanercept Market by Product
9.1.5.1.2 United States Etanercept Market by Application
9.1.5.2 Canada Etanercept Market
9.1.5.2.1 Canada Etanercept Market by Product
9.1.5.2.2 Canada Etanercept Market by Application
9.1.5.3 Mexico Etanercept Market
9.1.5.3.1 Mexico Etanercept Market by Product
9.1.5.3.2 Mexico Etanercept Market by Application
9.2. EUROPE
9.2.1 Europe Etanercept Market Overview
9.2.2 Europe Etanercept Market Forecasts and Analysis
9.2.3 Europe Etanercept Market Forecasts and Analysis - By Product
9.2.4 Europe Etanercept Market Forecasts and Analysis - By Application
9.2.5 Europe Etanercept Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Etanercept Market
9.2.5.1.1 Germany Etanercept Market by Product
9.2.5.1.2 Germany Etanercept Market by Application
9.2.5.2 France Etanercept Market
9.2.5.2.1 France Etanercept Market by Product
9.2.5.2.2 France Etanercept Market by Application
9.2.5.3 Italy Etanercept Market
9.2.5.3.1 Italy Etanercept Market by Product
9.2.5.3.2 Italy Etanercept Market by Application
9.2.5.4 Spain Etanercept Market
9.2.5.4.1 Spain Etanercept Market by Product
9.2.5.4.2 Spain Etanercept Market by Application
9.2.5.5 United Kingdom Etanercept Market
9.2.5.5.1 United Kingdom Etanercept Market by Product
9.2.5.5.2 United Kingdom Etanercept Market by Application
9.2.5.6 Rest of Europe Etanercept Market
9.2.5.6.1 Rest of Europe Etanercept Market by Product
9.2.5.6.2 Rest of Europe Etanercept Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Etanercept Market Overview
9.3.2 Asia-Pacific Etanercept Market Forecasts and Analysis
9.3.3 Asia-Pacific Etanercept Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Etanercept Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Etanercept Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Etanercept Market
9.3.5.1.1 Australia Etanercept Market by Product
9.3.5.1.2 Australia Etanercept Market by Application
9.3.5.2 China Etanercept Market
9.3.5.2.1 China Etanercept Market by Product
9.3.5.2.2 China Etanercept Market by Application
9.3.5.3 India Etanercept Market
9.3.5.3.1 India Etanercept Market by Product
9.3.5.3.2 India Etanercept Market by Application
9.3.5.4 Japan Etanercept Market
9.3.5.4.1 Japan Etanercept Market by Product
9.3.5.4.2 Japan Etanercept Market by Application
9.3.5.5 South Korea Etanercept Market
9.3.5.5.1 South Korea Etanercept Market by Product
9.3.5.5.2 South Korea Etanercept Market by Application
9.3.5.6 Rest of Asia-Pacific Etanercept Market
9.3.5.6.1 Rest of Asia-Pacific Etanercept Market by Product
9.3.5.6.2 Rest of Asia-Pacific Etanercept Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Etanercept Market Overview
9.4.2 Middle East and Africa Etanercept Market Forecasts and Analysis
9.4.3 Middle East and Africa Etanercept Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Etanercept Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Etanercept Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Etanercept Market
9.4.5.1.1 South Africa Etanercept Market by Product
9.4.5.1.2 South Africa Etanercept Market by Application
9.4.5.2 Saudi Arabia Etanercept Market
9.4.5.2.1 Saudi Arabia Etanercept Market by Product
9.4.5.2.2 Saudi Arabia Etanercept Market by Application
9.4.5.3 U.A.E Etanercept Market
9.4.5.3.1 U.A.E Etanercept Market by Product
9.4.5.3.2 U.A.E Etanercept Market by Application
9.4.5.4 Rest of Middle East and Africa Etanercept Market
9.4.5.4.1 Rest of Middle East and Africa Etanercept Market by Product
9.4.5.4.2 Rest of Middle East and Africa Etanercept Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Etanercept Market Overview
9.5.2 South and Central America Etanercept Market Forecasts and Analysis
9.5.3 South and Central America Etanercept Market Forecasts and Analysis - By Product
9.5.4 South and Central America Etanercept Market Forecasts and Analysis - By Application
9.5.5 South and Central America Etanercept Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Etanercept Market
9.5.5.1.1 Brazil Etanercept Market by Product
9.5.5.1.2 Brazil Etanercept Market by Application
9.5.5.2 Argentina Etanercept Market
9.5.5.2.1 Argentina Etanercept Market by Product
9.5.5.2.2 Argentina Etanercept Market by Application
9.5.5.3 Rest of South and Central America Etanercept Market
9.5.5.3.1 Rest of South and Central America Etanercept Market by Product
9.5.5.3.2 Rest of South and Central America Etanercept Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. ETANERCEPT MARKET, KEY COMPANY PROFILES
11.1. PFIZER INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. TAKEDA PHARMACEUTICAL COMPANY LTD
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. JOHNSON AND JOHNSON
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLAXOSMITHKLINE PHARMACEUTICALS LTD
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. SAMSUNG BIOEPIS CO., LTD
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. F. HOFFMANN-LA ROCHE LTD
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. CIPLA LIMITED
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. NOVARTIS INTERNATIONAL AG
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. CELLTRION INC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. IMMUNEX CORPORATION
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer Inc.
2. Takeda Pharmaceutical Company Ltd
3. Johnson and Johnson
4. GlaxoSmithKline Pharmaceuticals Ltd
5. Samsung Bioepis Co., Ltd
6. F. Hoffmann-La Roche Ltd
7. Cipla Limited
8. Novartis International AG
9. Celltrion Inc
10. Immunex Corporation
TIPRE00018520
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking